Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karla A. Moore is active.

Publication


Featured researches published by Karla A. Moore.


American Journal of Forensic Medicine and Pathology | 1999

Tissue distribution of tramadol and metabolites in an overdose fatality

Karla A. Moore; Stephen J. Cina; Robert Jones; Dale M. Selby; Barry Levine; Michael L. Smith

Tramadol (Ultram) is a centrally acting, synthetic analgesic agent. Although it has some affinity for the opiate receptors, tramadol is believed to exert its analgesic effect by inhibiting the re-uptake of norepinephrine and serotonin. There are several published cases of tramadols involvement in drug-related deaths and impairment. Reports of deaths involving tramadol alone with associated tissue concentrations are rare. This report documents a case in which tramadol overdose was identified as the cause of death. The following tramadol concentrations were found in various tissues: blood, 20 mg/L; urine, 110.2 mg/L; liver, 68.9 mg/kg; and kidney, 37.5 mg/kg. Tissue distributions of the two primary metabolites, N-desmethyl and O-desmethyl tramadol, are also reported. In each tissue or fluid except urine, the tramadol concentration was greater than either metabolite, consistent with other reports of drug-impaired drivers and postmortem cases. The O-desmethyl metabolite concentration was greater than the N-desmethyl metabolite concentration in all tissues; this is in contrast to other postmortem reports, in which the majority of cases report concentrations of O-desmethyl as less than those of N-desmethyl. This may be useful as an indicator of time lapse between ingestion and death.


Journal of Forensic Sciences | 1997

Tissue Distribution of Ketamine in a Mixed Drug Fatality

Karla A. Moore; Edward M. Kilbane; Robert Jones; Gary W. Kunsman; Barry Levine; Michael Smith

While reports of ketamine abuse are increasing, reports of ketamine deaths and tissue concentrations associated with fatalities are rare. We report here a case of a mixed drug fatality involving ketamine and ethanol. Ketamine analysis was carried out by gas chromatography with a nitrogen-phosphorus detector (NPD). We found the following tissue concentrations: blood 1.8 mg/L; urine 2.0 mg/L; brain 4.3 mg/kg; spleen 6.1 mg/kg; liver 4.9 mg/kg, and kidney 3.6 mg/kg. The blood ethanol concentration was 170 mg/dL. Because an empty nalbuphine ampule was found in the possession of the deceased, the blood was assayed for this opioid compound using a gas chromatography/mass spectrometry (GC/MS) method. None was detected at a limit of detection of 0.02 mg/L.


Forensic Science International | 1997

A comparison of ethanol concentrations in the occipital lobe and cerebellum

Karla A. Moore; Gary W. Kunsman; Barry Levine; Mary M. Herman; Juraj Cervenak; Thomas M. Hyde

While many publications have addressed the issue of ethanol concentration in brain tissue as a better indicator of impairment than blood alcohol concentration (BAC), very few have looked at the regional distribution of ethanol in the brain and its possible significance in postmortem sampling. This paper reports on the analysis of occipital pole and cerebellar hemisphere for ethanol in 25/brain samples obtained at autopsy from the brain collection of the National Institutes of Mental Health/Stanley Foundation. When available, these concentrations were compared to BAC. The average ratio of occipital lobe alcohol concentration (OAC) to BAC for cases which also had blood samples (18/24) was 0.9, SD = 0.5, with a range of 0-1.8; the average ratio of cerebellar alcohol concentration (CAC) to BAC for these cases was 0.6, SD = 0.4, range = 0-1.2. When only those cases with a BAC > or = 0.04 g/dl (14/18 cases) were considered, the average OAC/BAC and CAC/BAC ratios were 0.8 (SD = 0.4) and 0.7 (SD = 0.4), respectively. These distribution ratios are well within the ranges reported by other authors and do not significantly differ from each other. The cortical brain region available or selected for postmortem ethanol analysis is probably not critical.


Journal of Analytical Toxicology | 2001

Urine Concentrations of Ketamine and Norketamine Following Illegal Consumption

Karla A. Moore; Jason H. Sklerov; Barry Levine; Aaron Jacobs


Forensic Science International | 1999

Screening postmortem blood and tissues for nine cases of drugs of abuse using automated microplate immunoassay

Karla A. Moore; Christina Werner; Robert M. Zannelli; Barry Levine; Michael L. Smith


Journal of Analytical Toxicology | 1998

The Effect of Oral Dehydroepiandrosterone (DHEA) on the Urine Testosterone/Epitestosterone (T/E) Ratio in Human Male Volunteers

Thomas Z. Bosy; Karla A. Moore; Alphonse Poklis


Journal of Analytical Toxicology | 1999

Tissue distribution of mirtazapine (Remeron) in postmortem cases.

Karla A. Moore; Barry Levine; Michael L. Smith; Saffia Saki; Julie Schames; John E. Smialek


Transplantation proceedings | 1992

Psychosocial adjustment to illness : quality of life following liver transplantation

Karla A. Moore; Robert Jones; Peter W Angus; Kenneth J. Hardy; Graham D. Burrows


Journal of Analytical Toxicology | 2001

Applicability of Opiate Cutoffs to Opiate Intoxication Cases

Karla A. Moore; Joseph Addison; Barry Levine; John E. Smialek


Forensic Science International | 2000

Corrigendum to “Screening postmortem blood and tissues for nine classes of drugs of abuse using automated microplate immunoassay” [Forensic Sci. Int. 106 (1999) 93–102] ☆

Karla A. Moore; Christina Werner; Robert M Zanelli; Barry Levine; Michael L. Smith

Collaboration


Dive into the Karla A. Moore's collaboration.

Top Co-Authors

Avatar

Barry Levine

Armed Forces Institute of Pathology

View shared research outputs
Top Co-Authors

Avatar

Michael L. Smith

Armed Forces Institute of Pathology

View shared research outputs
Top Co-Authors

Avatar

Gary W. Kunsman

Armed Forces Institute of Pathology

View shared research outputs
Top Co-Authors

Avatar

Barry Levine

Armed Forces Institute of Pathology

View shared research outputs
Top Co-Authors

Avatar

Robert Jones

Armed Forces Institute of Pathology

View shared research outputs
Top Co-Authors

Avatar

John E. Smialek

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Mary M. Herman

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Thomas M. Hyde

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Aaron Jacobs

Armed Forces Institute of Pathology

View shared research outputs
Top Co-Authors

Avatar

Edward M. Kilbane

Armed Forces Institute of Pathology

View shared research outputs
Researchain Logo
Decentralizing Knowledge